Ilika says UK defence testing of its Goliath solid-state battery prototypes showed improved safety under extreme conditions, including controlled thermal behaviour compared with conventional lithium-ion cells...
New manufacturing infrastructure at the UK Battery Industrialisation Centre strengthens the pathway for Ilika’s solid state battery technology to move from development towards commercial scale production...
Graeme Purdy explains the significance of delivering commercial-grade electrodes, outlines their function in Stereax batteries, and highlights key applications across implantable and miniature medical technologies...
Ilika Plc delivers its first commercial-grade Stereax cathodes to Cirtec Medical, advancing production of the Stereax M300 solid-state battery. CEO Graeme Purdy explains the UK manufacturing strategy, growing medical device..
Ilika has completed its first revenue-generating order from Cirtec Medical, supplying commercial-grade Stereax electrodes for M300 batteries used in active implantable medical device applications...
Ilika will present its solid-state battery capabilities at The Battery Show Europe 2026 as it strengthens engagement with Europe’s battery manufacturing ecosystem...
Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London...
Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath..
Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for..
Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications...
Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves,..
Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat..
Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation,..
Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production...
Ilika says UK defence testing of its Goliath solid-state battery prototypes showed improved safety under extreme conditions, including controlled thermal behaviour compared with conventional lithium-ion cells...
New manufacturing infrastructure at the UK Battery Industrialisation Centre strengthens the pathway for Ilika’s solid state battery technology to move from development towards commercial scale production...
Graeme Purdy explains the significance of delivering commercial-grade electrodes, outlines their function in Stereax batteries, and highlights key applications across implantable and miniature medical technologies...
Ilika Plc delivers its first commercial-grade Stereax cathodes to Cirtec Medical, advancing production of the Stereax M300 solid-state battery. CEO Graeme Purdy explains the UK manufacturing strategy, growing medical device applications and the supply ramp ahead...
Ilika has completed its first revenue-generating order from Cirtec Medical, supplying commercial-grade Stereax electrodes for M300 batteries used in active implantable medical device applications...
Ilika will present its solid-state battery capabilities at The Battery Show Europe 2026 as it strengthens engagement with Europe’s battery manufacturing ecosystem...
Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London...
Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform...
Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme...
Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications...
Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational...
Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range...
Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap...
Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production...
